Michael Mrochen, PhD co-founded ClearSight Innovations in 2013. He is responsible for the product development as CTO. With over 15 years of experience in executing translational research projects, product development, and commercial execution in ophthalmology, Prof. Mrochen has authored more than 100 peer reviewed articles and book chapters as well as over 20 patents. He is one of the founders of the International Wavefront Congress and the International Corneal Cross Linking Congress. In 2014, he was ranged to be within the top 100 most influential people in ophthalmology and successfully sold his cross linking company IROC Innocross to a larger company.